Exxon Earnings Disappoint, but Dividend Not in Doubt
Our fair value estimate and narrow moat rating for the firm are intact.
Exxon (XOM) reported a near-doubling in second-quarter earnings, but the relative improvement lagged peers and fell below consensus estimates, sending shares lower. The shortfall largely resulted from maintenance activity in the upstream and chemical segments that negatively affected earnings. Nothing in the quarter altered our long-term outlook on the firm, leaving our fair value estimate and narrow moat rating intact. Second-quarter earnings surged to $3.4 billion from $1.7 billion the year before, led by increases in upstream and downstream earnings. Upstream earnings jumped to $1.2 billion from $294 million last year thanks to higher commodity prices, which offset a nearly 1% decline in production volumes. Quarter to quarter, Exxon’s production will likely fall and increase on maintenance activity and new project startups; however, the outlook through 2020 remains for little or no growth based on management’s latest guidance, although margins should improve with the addition of higher-margin production to the portfolio.
Downstream earnings increased to $1.4 billion from $825 million last year on higher volumes and wider industry margins. Chemical earnings slipped to $985 million from $1.2 billion last year, largely on higher maintenance activity.
Exxon generated sufficient free cash flow during the quarter to cover capital spending and the dividend. Through the first half of the year, Exxon generated $15.2 billion in operating cash flow, sufficient to fund its $7.5 billion capital expenditure and $6.4 billion in shareholder distributions. Although capital spending is running below full-year guidance, it will likely be back-end-loaded, as is typically the case, while two large acquisitions have yet to be completed. We still expect Exxon to easily fund its dividend, however, and place its break-even level around $40/barrel, the lowest of the group.
Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.
Allen Good does not own shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.